RLI Corp. (NYSE:RLI) Given Average Recommendation of “Hold” by Analysts

RLI Corp. (NYSE:RLIGet Free Report) has been assigned a consensus rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $63.00.

Several equities research analysts recently weighed in on the stock. Wall Street Zen upgraded shares of RLI from a “sell” rating to a “hold” rating in a research note on Saturday. Weiss Ratings upgraded RLI from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 29th. UBS Group set a $74.00 target price on RLI in a research note on Tuesday, July 28th. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and set a $74.00 target price (up from $70.00) on shares of RLI in a report on Tuesday, July 28th. Finally, Wells Fargo & Company cut RLI from an “equal weight” rating to an “underweight” rating and set a $57.00 price target on the stock. in a research report on Wednesday, July 29th.

Get Our Latest Research Report on RLI

Insider Activity

In other news, COO Jennifer L. Klobnak purchased 2,000 shares of the stock in a transaction dated Tuesday, May 19th. The stock was acquired at an average price of $53.42 per share, for a total transaction of $106,840.00. Following the completion of the transaction, the chief operating officer owned 102,318 shares of the company’s stock, valued at approximately $5,465,827.56. The trade was a 1.99% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Craig W. Kliethermes acquired 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The stock was purchased at an average cost of $52.00 per share, for a total transaction of $260,000.00. Following the acquisition, the chief executive officer owned 148,990 shares in the company, valued at approximately $7,747,480. This trade represents a 3.47% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders purchased 16,500 shares of company stock worth $858,955. 2.39% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Oppenheimer Asset Management Inc. bought a new stake in shares of RLI during the second quarter valued at about $2,604,000. Wasatch Advisors LP grew its position in RLI by 40.7% in the 2nd quarter. Wasatch Advisors LP now owns 3,631,273 shares of the insurance provider’s stock valued at $214,499,000 after buying an additional 1,051,318 shares in the last quarter. Handelsbanken Fonder AB grew its position in RLI by 37.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 38,060 shares of the insurance provider’s stock valued at $2,248,000 after buying an additional 10,400 shares in the last quarter. GAMMA Investing LLC increased its stake in RLI by 4.6% during the 2nd quarter. GAMMA Investing LLC now owns 5,534 shares of the insurance provider’s stock valued at $327,000 after buying an additional 242 shares during the period. Finally, Brighton Securities CORP. increased its stake in RLI by 12.2% during the 2nd quarter. Brighton Securities CORP. now owns 4,076 shares of the insurance provider’s stock valued at $241,000 after buying an additional 444 shares during the period. 77.89% of the stock is owned by institutional investors and hedge funds.

RLI Price Performance

RLI stock opened at $61.27 on Tuesday. RLI has a 1-year low of $47.26 and a 1-year high of $69.19. The firm has a fifty day moving average price of $57.21 and a two-hundred day moving average price of $57.50. The firm has a market cap of $5.62 billion, a price-to-earnings ratio of 12.87 and a beta of 0.38.

RLI (NYSE:RLIGet Free Report) last issued its earnings results on Wednesday, July 22nd. The insurance provider reported $0.83 earnings per share for the quarter, topping analysts’ consensus estimates of $0.72 by $0.11. RLI had a net margin of 22.22% and a return on equity of 17.61%. The company had revenue of $575.57 million for the quarter, compared to analysts’ expectations of $568.70 million. During the same period in the prior year, the company earned $0.82 earnings per share. The firm’s revenue was up 15.2% compared to the same quarter last year. As a group, analysts expect that RLI will post 2.85 EPS for the current fiscal year.

RLI Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 29th were paid a $0.18 dividend. The ex-dividend date was Friday, May 29th. This is a positive change from RLI’s previous quarterly dividend of $0.16. This represents a $0.72 dividend on an annualized basis and a yield of 1.2%. RLI’s dividend payout ratio (DPR) is 15.13%.

RLI Company Profile

(Get Free Report)

RLI Corporation (NYSE:RLI) is a specialty property and casualty insurance company focused on underwriting niche risks for businesses and individuals. Headquartered in Peoria, Illinois, the company operates through a network of independent agents and brokers, offering customized coverage solutions. RLI’s approach emphasizes disciplined underwriting, targeted product development and strong customer service to maintain profitability and long-term growth.

Founded in 1965 as Replacement Lens, Inc, RLI initially provided insurance for contact lens manufacturers before shifting its focus to specialty insurance in the 1980s.

Featured Stories

Analyst Recommendations for RLI (NYSE:RLI)

Receive News & Ratings for RLI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLI and related companies with MarketBeat.com's FREE daily email newsletter.